Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3703 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

AstraZeneca ends AtherGenics collaboration

AtheroGenics will reacquire all worldwide rights for AGI-1067 and will continue to develop the compound, the company said. AstraZeneca is responsible for providing transition support to AtheroGenics. “Based

New drug could help treat genetic diseases

Researchers from PTC and at the University of Pennsylvania School of Medicine have for the first time demonstrated restoration of muscle function in a mouse model of Duchenne’s

Abbott seeks approval for new cholesterol pill

Simcor contains Niaspan – used to raise HDL “good” cholesterol levels, and simvastatin – used to reduce LDL “bad” cholesterol levels. This combination is being submitted for FDA

AstraZeneca closes deal on MedImmune

The acquisition price represents a premium of approximately 53% to US-based MedImmune’s closing share price of $37.84 on 11th April, 2007, the day before the company indicated that

SuperGen sells anticancer agents to Intas

SuperGen will receive $600,000 shortly after signing with the balance due at the time of product transfer later this quarter. SuperGen will also sell for additional consideration certain

Sanofi blood thinner better than rival

The results of the trial showed that once daily administration of Lovenox 40mg was more effective than unfractionated heparin twice a day for the prevention of blood clots

AVI completes purchase of GMP manufacturing site

The 34,000-square-foot facility will house additional capability for the large-scale GMP production of AVI’s proprietary phosphorodiamidate morpholino oligomers (PMOs). Additional capacity for both of these processes will be

Baxter says drug delivery research encouraging

The study demonstrates that the insulin powder can be effectively administered using a dry powder inhaler designed for upper airway drug delivery. Each subject received a single dose